Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates

Sponsor
University of Texas at Austin (Other)
Overall Status
Recruiting
CT.gov ID
NCT06078137
Collaborator
(none)
200
1
2
12
16.6

Study Details

Study Description

Brief Summary

in clinical practice has been curbed by issues related to the variability in use of these tools for decision-making, and universally poor completion rates over time. Patients may not see the relevance of responding to questions about their health, and the results may not be reviewed by the clinician or presented and visualized with the patient. The questions may seem impersonal (e.g. too general and not directly assessing their individual goals, motivations, aspirations), irrelevant (e.g., asking about symptoms of depression when a person is seeking musculoskeletal specialty care) and insensitive (e.g., asking about sensitive subjects at the outset thereby disengaging the individual), and redundant or awkward (e.g., presenting questions that seem very similar or administered in strange orders). Finally, PROMs may also confer some burden (e.g., long PROM questionnaires often used for research may be unnecessarily burdensome for patient care), and provide logistical challenges (e.g., difficulties in administering the tools at the right time points), adding to a poor patient experience.

Condition or Disease Intervention/Treatment Phase
  • Other: Usual PROMs and new PROMs strategy
N/A

Detailed Description

The investigator sought to assess the impact of an enhanced and more personalized PROM strategy to overcome these barriers by providing i) a primer ahead of PROMs administration,

  1. simple 3-part survey capturing capability, comfort, and calm, iii) a short distress and misconception survey, iv) goal setting question, v) summary sheet of PRO scores, and vi) a commitment intervention. Patients will subsequently be requested to complete the CollaboRATE survey, JSPPE survey, and questions about their experience in relation to the new format of surveys (only if they were in the intervention group) before receiving a text message reminder around 6-weeks followed by a set of deprioritization questions and the 3-part capability, comfort, and calm survey.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Single (Participant)
Primary Purpose:
Basic Science
Official Title:
Impact of an Enhanced Patient Reported Outcome Measurement (PROM) Strategy on PROM Completion Rates, Decision Support, and Patient Experience: A Hybrid Effectiveness-Implementation Study
Actual Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Sep 1, 2024
Anticipated Study Completion Date :
Sep 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention Group

Patients randomized to intervention receive both usual Patient reported outcome measure (PROM) and new PROMs strategy (on the technology platform for English speakers and on REDCap/Qualtrix for Spanish Speakers) done after rooming.

Other: Usual PROMs and new PROMs strategy
Patients randomized to intervention receive both usual PROMs and new PROMs strategy

No Intervention: Control group

Patients go through the registration process which includes PROMs completion using Ipads. Enrolled in the room at the end of the visit.

Outcome Measures

Primary Outcome Measures

  1. Completion of 3-survey patient-reported outcome measure at 6-week follow-up via Text [through study completion, an average of 6 weeks]

    We will assess the completion of 3-survey patient-reported outcome measure at 6-week follow-up via Text.

  2. Completion of answered text [through study completion, an average of 6 weeks]

    We will assess the completion response rate.

  3. Completion of deprioritization options 1 or 2 at 6-week follow-up via text or email [through study completion, an average of 6 weeks]

    "1 = I got what I needed" "2 = I didn't receive anything useful" "3 = I'm still receiving care"

  4. Jefferson Scale of Patient's Perceptions of Physician Empathy [through study completion, an average of 6 weeks]

    The Jefferson Scale of Patient's Perceptions of Physician Empathy includes five 7-point scale questions and higher scores indicated greater perceived clinician empathy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 89 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

All new patients English and Spanish speakers

Exclusion criteria:

Cognitive deficiency precluding PROM completion Language other than English or Spanish

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas Health Austin Austin Texas United States 78701

Sponsors and Collaborators

  • University of Texas at Austin

Investigators

  • Principal Investigator: David Ring, MD, Professor of orthopedic surgery at The university of Texas at Austin

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
David Ring, Professor of Surgery and Perioperative Care Department, University of Texas at Austin
ClinicalTrials.gov Identifier:
NCT06078137
Other Study ID Numbers:
  • STUDY00001696
First Posted:
Oct 11, 2023
Last Update Posted:
Oct 11, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 11, 2023